Angiogenesis in psoriasis as a therapeutic target. Literature review.



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

One of the characteristic features of psoriasis is increased vascularization in the psoriatic plaque. It is known that this process occurs as a result of pathological angiogenesis, which leads to an increase of blood vessels in the lesion, increased proliferation of endothelial cells, vasodilation and increased permeability of the vascular wall, facilitating penetration of immune cells and increasing inflammation. Many signaling molecules are involved in the process of angiogenesis in psoriasis. The most important indicator of the severity of pathological angiogenesis is endothelial vascular growth factor (VEGF). The issue of using blood serum analysis for VEGF and diagnostic imaging techniques of the vascular network in psoriatic plaques to determine the severity of the process and the possibility of using additional treatment directions aimed at reducing vascularization is being considered. At the moment, the mechanisms of angiogenesis in psoriasis are being actively studied, and the possibilities of therapeutic influence on this link of pathogenesis are especially interesting. The authors present an analysis of the current literature on this topic, and suggest possible available treatment strategies based on the data obtained. Further research in this direction is needed to optimize the therapy of psoriasis, the main purpose of which will be to reduce the duration of treatment and prolong the time of remission.

Full Text

Restricted Access

About the authors

Nikolay G. Kochergin

The First Sechenov Moscow State Medical University (Sechenov University)

Email: nkocha@yandex.ru
ORCID iD: 0000-0001-7136-4053
SPIN-code: 1403-3031
Scopus Author ID: 6602082412

MD, Dr. Sci. (Med.), Professor

Russian Federation, Moscow

Anna A. Brezhneva

The First Sechenov Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: anna-brezhneva@mail.ru
ORCID iD: 0009-0002-2489-1269

MD, postgraduate

Russian Federation, Moscow

Olga S. Yazkova

Central polyclinic

Email: olesha230808@mail.ru
ORCID iD: 0000-0002-9644-4778
SPIN-code: 9548-9076

MD, Cand. Sci. (Med.)

Russian Federation, Moscow

Alexander A. Fadeev

The First Sechenov Moscow State Medical University (Sechenov University)

Email: fadeevalek@yandex.ru
ORCID iD: 0009-0000-6619-5056

MD, Cand. Sci. (Med.)

Moscow

References

  1. REFERENCES
  2. Olisova O.Yu., Kochergin N.G., Paramonov A.A., et al. [Clinical and genetic associations of T-cell receptors repertoire in psoriasis]. Patogenez [Pathogenesis]. 2023; 21(2): 47-54. (in Russian) doi: 10.25557/2310-0435.2023.02.47-54
  3. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis A Review April W. Armstrong, MD, MPH; Charlotte Read, MBBS, BSc, JAMA. 2020;323(19):1945-1960. doi: 10.1001/jama.2020.4006
  4. Kaushik SB, Lebwohl MG. Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents. J Am Acad Dermatol. 2019 Jan;80(1):27-40. doi: 10.1016/j.jaad.2018.06.057. Epub 2018 Jul 11. PMID: 30017705.
  5. Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019 Mar 23;20(6):1475. doi: 10.3390/ijms20061475. PMID: 30909615; PMCID: PMC6471628.
  6. Fitzpatrick's dermatology in clinical practice: In 3 vols. / D36 L.A. Goldsmith, S.I. Katz, B.A.Gilchrist, etc.; trans. from English; general ed. N.N. Potekaeva, A.N. Lvova. - 2nd edition, Spanish, revised, additional. – M. : Panfilov Publishing House, 2015 –. Vol. 1. – 2015. – 1168 p.: ill. ISBN 978-5-91839-060-3 (Vol. 1) ISBN 978-5-91839-059-7
  7. Ghoreschi K, Balato A, Enerbäck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021 Feb 20;397(10275):754-766. doi: 10.1016/S0140-6736(21)00184-7. Epub 2021 Jan 27. PMID: 33515492.
  8. Luengas-Martinez A, Paus R, Young HS. Antivascular endothelial growth factor-A therapy: a novel personalized treatment approach for psoriasis. Br J Dermatol. 2022 May;186(5):782-791. doi: 10.1111/bjd.20940. Epub 2022 Mar 17. Erratum in: Br J Dermatol. 2022 Oct;187(4):625. PMID: 34878645; PMCID: PMC9313866.
  9. Lee HJ, Hong YJ, Kim M. Angiogenesis in Chronic Inflammatory Skin Disorders. Int J Mol Sci. 2021 Nov 7;22(21):12035. doi: 10.3390/ijms222112035. PMID: 34769465; PMCID: PMC8584589.
  10. Coimbra S, Oliveira H, Reis F, et al. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol. 2010 Dec;163(6):1282-90. doi: 10.1111/j.1365-2133.2010.09992.x. Epub 2010 Nov 8. PMID: 20716219.
  11. Pritulo OA, Petrov AA. Comprehensive assessment of the dynamics of angiogenesis in patients with psoriasis treated with methotrexate. Vestnik Dermatologii i Venerologii. 2023;99(1):37–47. doi: https://doi.org/10.25208/vdv1387
  12. Socha M, Kicinski P, Feldo M, et al. Assessment of selected angiogenesis markers in the serum of middle-aged male patients with plaque psoriasis. Dermatol Ther. 2021 Jan;34(1):e14727. doi: 10.1111/dth.14727. Epub 2021 Jan 6. PMID: 33381893.
  13. Hanssen SCA, van der Vleuten CJM, van Erp PEJ, et al. The effect of adalimumab on the vasculature in psoriatic skin lesions. J Dermatolog Treat. 2019 May;30(3):221-226. doi: 10.1080/09546634.2018.1506082. Epub 2018 Oct 9. PMID: 30074865.
  14. Hou H, Li J, Wang J, et al. ITGA9 Inhibits Proliferation and Migration of Dermal Microvascular Endothelial Cells in Psoriasis. Clin Cosmet Investig Dermatol. 2022 Dec 20;15:2795-2806. doi: 10.2147/CCID.S394398. PMID: 36573168; PMCID: PMC9789714.
  15. Dudley AC, Griffioen AW. Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis. 2023 Aug;26(3):313-347. doi: 10.1007/s10456-023-09876-7. Epub 2023 Apr 15. PMID: 37060495; PMCID: PMC10105163.
  16. Zhou L, Wang J, Liang J, et al. Psoriatic mesenchymal stem cells stimulate the angiogenesis of human umbilical vein endothelial cells in vitro. Microvasc Res. 2021 Jul;136:104151. doi: 10.1016/j.mvr.2021.104151. Epub 2021 Mar 1. PMID: 33662409.
  17. Han Q, Niu X, Hou R, et al. Dermal mesenchymal stem cells promoted adhesion and migration of endothelial cells by integrin in psoriasis. Cell Biol Int. 2021 Feb;45(2):358-367. doi: 10.1002/cbin.11492. Epub 2020 Nov 8. PMID: 33079476.
  18. Li J, Hou H, Zhou L, et al. Increased angiogenesis and migration of dermal microvascular endothelial cells from patients with psoriasis. Exp Dermatol. 2021 Jul;30(7):973-981. doi: 10.1111/exd.14329. Epub 2021 Mar 22. PMID: 33751661.
  19. Gong J, Yang H, Qi D, Tang X. The association of serum vascular endothelial growth factor levels and psoriasis vulgaris: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020 Aug 14;99(33):e21565. doi: 10.1097/MD.0000000000021565. PMID: 32872007; PMCID: PMC7437804.
  20. Mohta A, Mohta A, Ghiya BC. Assessing the Association between Psoriasis and Cardiovascular Ischemia: An Investigation of Vascular Endothelial Growth Factor, Cutaneous Angiogenesis, and Arterial Stiffness. Indian Dermatol Online J. 2023 Aug 10;14(5):653-657. doi: 10.4103/idoj.idoj_246_23. PMID: 37727549; PMCID: PMC10506815.
  21. Zhu WJ, Li P, Wang L, Xu YC. Hypoxia-inducible factor-1: A potential pharmacological target to manage psoriasis. Int Immunopharmacol. 2020 Sep;86:106689. doi: 10.1016/j.intimp.2020.106689. Epub 2020 Jun 22. PMID: 32585606.
  22. Xian D, Song J, Yang L, et al. Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses. Oxid Med Cell Longev. 2019 Apr 16;2019:2304018. doi: 10.1155/2019/2304018. PMID: 31178954; PMCID: PMC6501144.
  23. Luengas-Martinez A, Ismail D, Paus R, Young HS. Inhibition of vascular endothelial growth factor-A downregulates angiogenesis in psoriasis: A pilot study. Skin Health Dis. 2023 May 15;3(5):e245. doi: 10.1002/ski2.245. PMID: 37799359; PMCID: PMC10549813.
  24. Kurz B, Berneburg M, Bäumler W, Karrer S. Phototherapy: Theory and practice. J Dtsch Dermatol Ges. 2023 Aug;21(8):882-897. doi: 10.1111/ddg.15126. Epub 2023 Jul 24. PMID: 37485907.
  25. Chua RA, Arbiser JL. The role of angiogenesis in the pathogenesis of psoriasis. Autoimmunity. 2009 Nov;42(7):574-9. doi: 10.1080/08916930903002461. PMID: 19863376.
  26. Olisova O.Yu., Kayumova L.N., Smirnov K.V., et al. General cryotherapy with the use of cryocapsule ICEQUEEN in patients with various dermatoses. Russian Journal of Skin and Venereal Diseases (Rossiyskii Zhurnal Kozhnykh i Venericheskikh Boleznei). 2017; 20(1): 15-20. (in Russian). DOI: http://dx.doi.org/10.18821/1560-9588-2017-20-1-15-20
  27. Tabisz H, Modlinska A, Kujawski S, et al. Whole-body cryotherapy as a treatment for chronic medical conditions? Br Med Bull. 2023 Jun 21;146(1):43-72. doi: 10.1093/bmb/ldad007. PMID: 37170956.
  28. Allan R, Malone J, Alexander J, et al. Cold for centuries: a brief history of cryotherapies to improve health, injury and post-exercise recovery. Eur J Appl Physiol. 2022 May;122(5):1153-1162. doi: 10.1007/s00421-022-04915-5. Epub 2022 Feb 23. PMID: 35195747; PMCID: PMC9012715.
  29. Hohenauer E, Costello JT, Deliens T, et al. Partial-body cryotherapy (-135°C) and cold-water immersion (10°C) after muscle damage in females. Scand J Med Sci Sports. 2020 Mar;30(3):485-495. doi: 10.1111/sms.13593. Epub 2019 Nov 27. PMID: 31677292; PMCID: PMC7027844.
  30. Kujawski S, Newton JL, Morten KJ, Zalewski P. Whole-body cryostimulation application with age: A review. J Therm Biol. 2021 Feb;96:102861. doi: 10.1016/j.jtherbio.2021.102861. Epub 2021 Jan 21. PMID: 33627288.
  31. Zembron-Lacny A, Morawin B, Wawrzyniak-Gramacka E, et al. Multiple Cryotherapy Attenuates Oxi-Inflammatory Response Following Skeletal Muscle Injury. Int J Environ Res Public Health. 2020 Oct 27;17(21):7855. doi: 10.3390/ijerph17217855. PMID: 33120891; PMCID: PMC7663269.
  32. Guillot X, Tordi N, Mourot L, et al. Cryotherapy in inflammatory rheumatic diseases: a systematic review. Expert Rev Clin Immunol. 2014 Feb;10(2):281-94. doi: 10.1586/1744666X.2014.870036. Epub 2013 Dec 18. PMID: 24345205.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86501 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г
.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies